Moderna (MRNA) Q1 2024 Earnings Call Transcript
MRNA earnings call for the period ending March 31, 2024.
Stay updated with breaking news from Generation Bio. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
MRNA earnings call for the period ending March 31, 2024.
Generation Bio Co. (NASDAQ:GBIO – Get Free Report) has earned an average rating of “Hold” from the six research firms that are currently covering the firm, MarketBeat Ratings reports. Four investment analysts have rated the stock with a hold rating and two have given a buy rating to the company. The average 1-year price target […]
EQS-News: BB BIOTECH AG / Key word: Interim Report BB Biotech presents solid first-quarter results; biotech stock market impacted by shifting views on interest rates...
22.04.2024 - CAMBRIDGE, Mass., April 22, 2024 (GLOBE NEWSWIRE) - Generation Bio Co. (Nasdaq:GBIO) a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases, today announced that six abstracts highlighting ...
CAMBRIDGE, Mass., April 22, 2024 -- Generation Bio Co. a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases, today announced that six abstracts...